GH Research PLC Ordinary Shares
GHRS
GHRS: GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
moreShow GHRS Financials
Recent trades of GHRS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GHRS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on GHRS's company Twitter account
Number of mentions of GHRS in WallStreetBets Daily Discussion
Recent insights relating to GHRS
Recent picks made for GHRS stock on CNBC
ETFs with the largest estimated holdings in GHRS
Flights by private jets registered to GHRS